Market Rumors 05/18:

Sepracor (Nasdaq: SEPR): speculation Medicare will reduce reimbursement payments for the company's asthma drug Xopenex.

This article: 217 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE